Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$302,070,554
+$147,535,183 QoQ
Shares Held
5,551,747
+54.1% QoQ
Ownership
2.24%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#11
of 739 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,016,183,849 across 217 Biotechnology names. EXEL ranks #3 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $302,070,554 | 5,551,747 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $154,535,371 | 3,603,063 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $81,524,018 | 1,860,005 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $9,310,424 | 225,434 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $26,596,240 | 603,363 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $26,308,527 | 712,582 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $53,997,681 | 1,621,552 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $33,755,396 | 1,300,786 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $12,674,652 | 564,070 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,564,868 | 529,493 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $20,490,818 | 854,140 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $32,766,171 | 1,499,596 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,790,988 | 512,349 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,454,254 | 693,161 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $23,283,615 | 1,451,597 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $24,640,366 | 1,571,452 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $37,026,933 | 1,778,431 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $28,505,734 | 1,257,421 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $32,739,095 | 1,790,979 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $15,724,354 | 743,820 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,236,203 | 232,503 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $10,037,798 | 444,347 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $9,465,132 | 471,606 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $14,597,799 | 597,047 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $12,885,407 | 542,772 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $11,883,469 | 690,097 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||